Dental Implants Industry Overview

 

The global dental implants market size was valued at USD 4.99 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 9.8% from 2024 to 2030.

 

Increasing applications of dental implants in various therapeutic areas along with rising demand for prosthetics are some of the key factors expected to boost the industry growth. Prosthetics play a major role in propelling the demand for these implants through oral rehabilitation, which helps in restoring the oral function and facial form of a patient. Acceptance level for dental implants is increasing among patients and dental surgeons due to limitations of removable prosthetics, such as discomfort, lack of natural appearance, and need for maintenance.

 

Gather more insights about the market drivers, restrains and growth of the Dental Implants Market

 

Prosthetics mounted on dental implants do not encroach on soft tissues and enhance aesthetics, which is further expected to drive the industry. The industry witnessed a minor setback due to the COVID-19 pandemic in the second and third quarters of 2020 due to supply chain bottlenecks and the closure of dental clinics. However, after the second quarter of 2020, dental procedures started to resume leading to a full market recovery by 2021. Companies like Straumann, which has a comprehensive portfolio of implants and implant solutions namely Neodent, Medentika, and Anthogyr, reported that their industry share increased from 27% to 29% from 2020 to 2021. This implies that the company expanded its customer base and geographical presence considerably post-pandemic.

 

An increasing number of dental injuries, owing to road accidents and sports injuries, are also some of the major factors favoring the demand for dental implants. The World Health Organization (WHO) data suggests that nearly 10 million people are injured or disabled due to road accidents every year. In addition, according to the American Academy for Implant Dentistry, over 15 million people in the U.S. undergo bridge and crown replacements for missing teeth every year, thus facilitating the demand for dental implants. Dental implants are long-term replacements preserving adjacent teeth, which are ground in the case of bridges. It is considered the only restorative technique that preserves and stimulates natural bone and also acts as a stable support for prosthetics (dentures).

 

Browse through Grand View Research's Medical Devices Industry Research Reports.

 

 

Dental Implants Market Segmentation

 

Grand View Research has segmented the dental implants market on the basis of on implant type and region:

 

Dental Implants Implant Type Outlook (Revenue, USD Million, 2018 - 2030)

 

  • Titanium Implants
  • Zirconia Implants

 

Dental Implants Regional Outlook (Revenue, USD Million, 2018 - 2030)

 

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Austria
    • The Netherlands
    • Poland
    • Romania
    • Czech Republic
    • Greece
    • Sweden
    • Portugal
    • Denmark
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • Kuwait
    • UAE

 

Key Companies profiled:

  • BioHorizons IPH, Inc.
  • Nobel Biocare Services AG
  • Zimmer Biomet Holdings, Inc.
  • OSSTEM IMPLANT
  • Institut Straumann AG
  • Bicon, LLC
  • Leader Italy
  • Anthogyr SAS
  • DENTIS
  • DENTSPLY Sirona
  • DENTIUM Co., Ltd.
  • T-Plus Implant Tech. Co.
  • KYOCERA Medical Corp.

 

Recent Developments

 

  • In May 2023, Straumann announced the acquisition of GalvoSurge, a manufacturer of dental medical devices based in Switzerland. The company specializes in implant care as well as maintenance solutions, with its concept for supporting peri-implantitis treatment - the GalvoSurge Dental Implant Cleaning System GS 1000 - holding a CE mark and being in the market since 2020.
  • In May 2023, T-Plus announced that its ST implant system had been made available for sale in the Chinese market, post an 8-year NMPA registration procedure.
  • In March 2023, Dentsply Sirona introduced the ‘DS OmniTaper Implant System’ at the 2023 Academy of Osseointegration (AO) Annual Meeting in Phoenix, Arizona. The solution forms a part of the company’s EV Implant Family, alongside the ‘DS PrimeTaper Implant System’ and the ‘Astra Tech Implant System’.
  • In January 2023, Nobel Biocare announced a partnership with Mimetis Biomaterials S.L., launching the ‘creos syntogain’ biomimetic bone graft substitute. This has helped Nobel Biocare to expand its regenerative solutions portfolio under the creos brand, adding to its creos xenoprotect, creos xenogain, creos syntoprotect, and creos mucogain offerings.

 

Order a free sample PDF of the Dental Implants Market Intelligence Study, published by Grand View Research.